NIH-funded research Career grant

How gut bacteria affect immune responses related to allergies

Official title: Microbial regulation of intestinal tuft cell homeostasis

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11001957 · Data updated 2026-11-12

This study is looking at how certain cells in your gut and the bacteria living there can affect your immune system, especially when it comes to allergies and infections, with the hope of finding new ways to treat these issues for people like you.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startApril 1, 2023
Project endDecember 31, 2027
Funding year2025
Award (this year)$140,271
NIH project number5K01DK135647-03
Project IDNIH-11001957 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with allergic diseases or conditions influenced by type 2 immune responses.

Less likely to help

Patients without allergic conditions or those not affected by type 2 immune responses may not benefit from this research.

What this research studies

This research investigates the role of intestinal tuft cells and the gut microbiota in regulating immune responses, particularly those related to allergies and helminth infections. It aims to understand how intestinal stem cells influence tuft cell differentiation and how commensal bacteria affect type 2 immune responses. By exploring these interactions, the research seeks to uncover new mechanisms that could lead to innovative treatments for type 2-driven intestinal diseases. Patients may benefit from insights that could inform microbiota-based therapies for allergic conditions.

Why it matters

Potential benefit: If successful, this research could lead to new microbiota-based treatments for patients suffering from allergic diseases.

How similar studies have gone: Previous research has shown promising results in understanding the role of gut microbiota in immune regulation, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Eshleman, Emily M. — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Eshleman, Emily M.

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.